- Home
- ADSK vs EW Comparison
ADSK vs EW Comparison
Compare ADSK & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADSK | EW |
|---|---|---|
| Founded | 1982 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.1B | 49.5B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | ADSK | EW |
|---|---|---|
| Price | $277.54 | $82.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 26 | 21 |
| Target Price | ★ $364.27 | $96.16 |
| AVG Volume (30 Days) | 1.4M | ★ 3.1M |
| Earning Date | 02-26-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.41 | N/A |
| EPS | ★ 5.15 | 2.33 |
| Revenue | ★ $6,888,000,000.00 | $5,883,800,000.00 |
| Revenue This Year | $19.10 | $14.29 |
| Revenue Next Year | $11.20 | $9.68 |
| P/E Ratio | $53.59 | ★ $36.54 |
| Revenue Growth | ★ 15.55 | 10.60 |
| 52 Week Low | $232.67 | $65.94 |
| 52 Week High | $329.09 | $87.89 |
Technical Indicators
Market Signals| Indicator | ADSK | EW |
|---|---|---|
| Relative Strength Index (RSI) | 32.35 | 40.39 |
| Support Level | $282.51 | $83.93 |
| Resistance Level | $296.80 | $86.60 |
| Average True Range (ATR) | 5.87 | 1.55 |
| MACD | -2.19 | -0.34 |
| Stochastic Oscillator | 12.22 | 1.04 |
Price Performance
Historical ComparisonAbout ADSK Autodesk Inc.
Founded in 1982, Autodesk is a multinational software company best known for pioneering computer-aided design, or CAD, with its AutoCAD product. Nowadays, Autodesk provides design software for a variety of verticals, including architecture & construction, manufacturing, and media & entertainment. Autodesk products have been used in some of the world's most iconic landmarks, like Burj Khalifa, and well-known movie titles like Avatar.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.